WO2022050694A9 - 연골 또는 골 질환의 예방 또는 치료용 생체모사 조직 접착성 하이드로젤 패치 - Google Patents

연골 또는 골 질환의 예방 또는 치료용 생체모사 조직 접착성 하이드로젤 패치 Download PDF

Info

Publication number
WO2022050694A9
WO2022050694A9 PCT/KR2021/011780 KR2021011780W WO2022050694A9 WO 2022050694 A9 WO2022050694 A9 WO 2022050694A9 KR 2021011780 W KR2021011780 W KR 2021011780W WO 2022050694 A9 WO2022050694 A9 WO 2022050694A9
Authority
WO
WIPO (PCT)
Prior art keywords
hydrogel patch
preventing
bone diseases
treating cartilage
adhesive hydrogel
Prior art date
Application number
PCT/KR2021/011780
Other languages
English (en)
French (fr)
Other versions
WO2022050694A1 (ko
Inventor
조승우
최수정
전은제
이종승
Original Assignee
주식회사 세라트젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 세라트젠 filed Critical 주식회사 세라트젠
Priority to CN202180053740.XA priority Critical patent/CN116113403A/zh
Priority to EP21864653.7A priority patent/EP4190316A1/en
Publication of WO2022050694A1 publication Critical patent/WO2022050694A1/ko
Publication of WO2022050694A9 publication Critical patent/WO2022050694A9/ko
Priority to US18/176,890 priority patent/US20230201109A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

본 발명은 페놀기가 수식된 생체적합성 고분자를 포함하는 하이드로젤 패치; 및 상기 하이드로젤 패치에 담지된 연골 또는 골 질환 치료용 약물을 포함하는 연골 또는 골 질환의 예방 또는 치료용 하이드로젤 패치에 관한 것이다.
PCT/KR2021/011780 2020-09-01 2021-09-01 연골 또는 골 질환의 예방 또는 치료용 생체모사 조직 접착성 하이드로젤 패치 WO2022050694A1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN202180053740.XA CN116113403A (zh) 2020-09-01 2021-09-01 用于预防或治疗软骨或骨性疾病的仿生组织粘合性水凝胶贴片
EP21864653.7A EP4190316A1 (en) 2020-09-01 2021-09-01 Biomimetic tissue-adhesive hydrogel patch for preventing or treating cartilage or bone diseases
US18/176,890 US20230201109A1 (en) 2020-09-01 2023-03-01 Bio-inspired tissue-adhesive hydrogel patch for preventing or treating cartilage or bone disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200111332A KR102483403B1 (ko) 2020-09-01 2020-09-01 연골 또는 골 질환의 예방 또는 치료용 생체모사 조직 접착성 하이드로젤 패치
KR10-2020-0111332 2020-09-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US18/176,890 Continuation US20230201109A1 (en) 2020-09-01 2023-03-01 Bio-inspired tissue-adhesive hydrogel patch for preventing or treating cartilage or bone disease

Publications (2)

Publication Number Publication Date
WO2022050694A1 WO2022050694A1 (ko) 2022-03-10
WO2022050694A9 true WO2022050694A9 (ko) 2022-05-12

Family

ID=80491823

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2021/011780 WO2022050694A1 (ko) 2020-09-01 2021-09-01 연골 또는 골 질환의 예방 또는 치료용 생체모사 조직 접착성 하이드로젤 패치

Country Status (5)

Country Link
US (1) US20230201109A1 (ko)
EP (1) EP4190316A1 (ko)
KR (1) KR102483403B1 (ko)
CN (1) CN116113403A (ko)
WO (1) WO2022050694A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240019910A (ko) * 2022-08-05 2024-02-14 주식회사 씨케이리제온 상처 치유 촉진용 또는 흉터 최소화용 하이드로젤 패치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101103423B1 (ko) * 2009-09-04 2012-01-06 아주대학교산학협력단 생체 주입형 조직 접착성 하이드로젤 및 이의 생의학적 용도
WO2013180457A1 (ko) * 2012-05-29 2013-12-05 한국교통대학교 산학협력단 접착특성을 갖는 항균 유기 공중합체, 그 유기 공중합체의 제조방법, 그 유기 공중합체가 코팅된 항균 코팅필름 및 그 코팅필름의 코팅방법
CN109526207B (zh) * 2017-03-14 2022-11-25 仰卧疗法有限公司 水凝胶贴片
KR20200017625A (ko) * 2018-08-09 2020-02-19 (주)앰틱스바이오 생체분자 또는 약물의 생체 내 전달을 위한 수식된 히알루론산 유도체의 용도

Also Published As

Publication number Publication date
CN116113403A (zh) 2023-05-12
KR102483403B1 (ko) 2022-12-30
KR20220029249A (ko) 2022-03-08
EP4190316A1 (en) 2023-06-07
WO2022050694A1 (ko) 2022-03-10
US20230201109A1 (en) 2023-06-29

Similar Documents

Publication Publication Date Title
MX2020003351A (es) Metodos, composiciones y elementos implantables que comprenden celulas activas.
AU2018236629A8 (en) Hydrogel patch
WO2009005790A3 (en) Sterile thiol-derivatized hyaluronic acid polymer compositions and uses thereof
AU2014290512A8 (en) Methods, systems, and compositions for promoting bone growth
EP1609468A3 (en) A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
MX2014004458A (es) Hebra de acido hialuronico reticulado y metodos de uso de las mismas.
PH12020550032A1 (en) Gel comprising chlorhexidine
WO2019102380A8 (en) Therapeutic treatment of breast cancer based on c-maf status
WO2022050694A9 (ko) 연골 또는 골 질환의 예방 또는 치료용 생체모사 조직 접착성 하이드로젤 패치
ATE534414T1 (de) Behandlung von osteoporose
PH12019501469A1 (en) Compositions and methods for treating biofilms
MX2021005421A (es) Macrólidos de 13 miembros con sustitución cíclica en c10 y usos de los mismos.
MX2022006467A (es) Biomateriales para la prevención y el tratamiento de enfermedades tisulares.
Lohsiriwat et al. Augmentation rhinoplasty with custom-made S-shape silicone implant in Asians: a 15-year experience
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
MX2021005423A (es) Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos.
BR112022025845A2 (pt) Composição biocompatível, preenchimento de tecidos e método de tratamento ou prevenção de um distúrbio, doença ou condição
EP4252776A3 (en) Compositions and methods for treating ocular diseases
NZ723177A (en) Implant comprising fgf-18
EP3811951A4 (en) PHARMACEUTICAL COMPOSITION WITH HYALURONIC ACID AND STEM CELLS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CARTILAGE DAMAGE
EA201790382A1 (ru) Способы лечения периимплантита
ZA202206990B (en) High molecular weight esthetic compositions
MX2023004450A (es) Combinaciones de péptidos bioactivos novedosas y usos de estas.
WO2020061067A3 (en) Compositions and methods for treating bone injury
MX2017017192A (es) Biopolimero de quitosano y poloxamero 407 obtenido por irradiacion gamma que exhibe propiedades fisicoqumicas y biologicas para la reparacion de heridas.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21864653

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021864653

Country of ref document: EP

Effective date: 20230228

NENP Non-entry into the national phase

Ref country code: DE